Veterinary Medicines

KELAPROFEN 100 mg/ml

Authorised
  • Ketoprofen
Download as PDF

Product identification

Medicine name:
KELAPROFEN 100 mg/ml
KELAPROFEN 100 MG/ML SOLUTION INJECTABLE POUR BOVINS EQUINS ET PORCINS
Active substance:
  • Ketoprofen
Target species:
  • Cattle
  • Horse
  • Pig
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Ketoprofen
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
    • Horse
    • Pig
  • Intravenous use
    • Cattle
    • Horse
    • Pig
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:
  • box containing 12 vials of 250 ml
  • box containing 12 vials of 100 ml
  • box containing 12 vials of 50 ml
  • box containing 10 vials of 250 ml
  • box containing 10 vials of 100 ml
  • box containing 10 vials of 50 ml
  • box containing 6 vials of 250 ml
  • box containing 6 vials of 100 ml
  • box containing 6 vials of 50 ml
  • box containing 1 vial of 250 ml
  • box containing 1 vial of 100 ml
  • box containing 1 vial of 50 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
  • Kela - Kempisch Laboratorium - Kela Laboratoria
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/2610381 1/2011
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0160/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 21/12/2023
Download
French (PDF)
Published on: 5/07/2022
Download

Package Leaflet

English (PDF)
Published on: 21/12/2023
Download

Labelling

English (PDF)
Published on: 21/12/2023
Download

eu-PUAR-esv0160001-dcp-kelaprofen--100-mg-ml-en.pdf

English (PDF)
Published on: 21/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."